£1.5m boost to penicillin plant
GSK Irvine expansion creates 55 new jobs.
First Minister Nicola Sturgeon yesterday announced £1.5 million funding for pharmaceutical company GlaxoSmithKline towards the extension of their plant in Irvine, creating 55 new jobs.
The company will receive a Scottish Enterprise Regional Selective Assistance (RSA) grant to extend their Potassium Clavulanate (Clav) Plant, which produces penicillin.
The Irvine facility has been expanded to meet the growing demand from the developing world and emerging markets for antibiotics and forms part of the company’s total investment of more than £200 million between their sites in Irvine and Montrose since 2013.
Speaking at the official opening of the new facility in Irvine, the First Minister said yesterday:
“GSK is a global leader in the development of medicines and a great example of a highly innovative company that is benefiting from what Scotland has to offer as an attractive location of choice for global life sciences companies.
“Their further investment in Scotland is testament to our thriving life sciences industry and its position as a key growth sector for the Scottish economy. Their continued commitment across their sites in Scotland is proof of the skill and value of the Scottish workforce.
“Last week I launched, A Manufacturing Future for Scotland – an action plan outlining our commitment to delivering new initiatives that stimulate innovation, improve productivity and increase investment in the Scottish manufacturing sector in order that it can better compete globally.
“Scotland has a long established reputation for innovation and research capability and a highly diverse manufacturing sector.
“We are committed to working with industry and with higher and further education institutions to see this develop further.”
Sir Andrew Witty, GSK CEO, said yesterday:
“We’re delighted to be opening a new facility in Scotland, where we have a long-standing commitment to manufacturing, which will continue in the near and distant future. The impact of this new facility will be felt here and abroad, with more antibiotics produced for people in countries where this sort of medicine is desperately needed.”
Adrian Gillespie, Scottish Enterprise Managing Director of Operations said yesterday:
“Today marks a significant milestone for GSK and Scotland’s life sciences sector. Since 2009 we’ve worked intensively with the company helping deliver its ambitious growth plans. “This latest support of £1.5 million RSA funding helped secure the company’s investment in Scotland and the creation of 55 new jobs. GSK is an important contributor to the Scottish economy and together we will continue to support its growth ambition in Scotland.”
Latest News from
Joint Housing Policy and Delivery Group final report20/01/2022 15:05:00
Final report of the Joint Housing Policy and Delivery Group.
Short-term lets legislation approved20/01/2022 13:05:00
All short-term let properties will require a licence to ensure they are safe and the people providing them are suitable, under legislation approved by the Scottish Parliament.
New Drug Deaths Taskforce vice-chair20/01/2022 12:05:00
Former Chief Nursing Officer takes up the post.
Omicron measures to be lifted19/01/2022 11:05:00
Public asked to be cautious while case numbers are still high.
Vaccinations for youngsters with specific medical conditions19/01/2022 10:05:00
Children aged five to 11 years old who have specific medical conditions which place them at greater risk from COVID-19 will be invited for their first vaccination from this week onwards.
Slashing carbon emissions across Scotland18/01/2022 15:05:00
Funding is being awarded to deliver carbon-cutting projects across the country.
Restorative justice and empathy-based interventions for animal welfare and wildlife crimes18/01/2022 12:05:00
This review summarises the available evidence on the use of community-based restorative justice and empathy-based interventions in animal welfare and wildlife crimes.
Offshore wind development18/01/2022 09:10:00
First Minister hails “truly historic” opportunity of ScotWind.